首页> 外文OA文献 >UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
【2h】

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.

机译:UKPDS结果模型2:使用来自30年英国前瞻性糖尿病研究:UKPDS 82的数据模拟2型糖尿病患者终生健康结果的模型的新版本。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIMS/HYPOTHESIS: The aim of this project was to build a new version of the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS-OM1), a patient-level simulation tool for predicting lifetime health outcomes of people with type 2 diabetes mellitus. METHODS: Data from 5,102 UKPDS patients from the 20 year trial and the 4,031 survivors entering the 10 year post-trial monitoring period were used to derive parametric proportional hazards models predicting absolute risk of diabetes complications and death. We re-estimated the seven original event equations and estimated new equations for diabetic ulcer and some second events. The additional data permitted inclusion of new risk factor predictors such as estimated GFR. We also developed four new equations for all-cause mortality. Internal validation of model predictions of cumulative incidence of all events and death was carried out and a contemporary patient-level dataset was used to compare 10 year predictions from the original and the new models. RESULTS: Model equations were based on a median 17.6 years of follow-up and up to 89,760 patient-years of data, providing double the number of events, greater precision and a larger number of significant covariates. The new model, UKPDS-OM2, is internally valid over 25 years and predicts event rates for complications, which are lower than those from the existing model. CONCLUSIONS/INTERPRETATION: The new UKPDS-OM2 has significant advantages over the existing model, as it captures more outcomes, is based on longer follow-up data, and more comprehensively captures the progression of diabetes. Its use will permit detailed and reliable lifetime simulations of key health outcomes in people with type 2 diabetes mellitus.
机译:目的/假设:该项目的目的是建立新版的英国前瞻性糖尿病研究(UKPDS)结果模型(UKPDS-OM1),这是一种用于预测2型糖尿病患者终生健康结果的患者水平模拟工具的。方法:使用来自20年试验的5,102例UKPDS患者和进入10年试验后监测期的4,031名幸存者的数据,得出预测糖尿病并发症和死亡绝对风险的参数比例风险模型。我们重新估计了七个原始事件方程,并估计了糖尿病溃疡和一些第二事件的新方程。附加数据允许包含新的危险因素预测因子,例如估计的GFR。我们还开发了四个新的全因死亡率方程。对所有事件和死亡的累积发生率的模型预测进行了内部验证,并使用了当代患者水平的数据集来比较原始模型和新模型的10年预测。结果:模型方程式是基于平均17.6年的随访和多达89,760个患者-年的数据,从而提供了两倍的事件发生率,更高的精确度和更多的重要协变量。新模型UKPDS-OM2在内部有效期超过25年,并预测并发症的发生率,该发生率低于现有模型的发生率。结论/解释:新的UKPDS-OM2与现有模型相比具有显着优势,因为它可捕获更多结果,基于更长的随访数据,并且可以更全面地捕获糖尿病的进展。它的使用将允许对2型糖尿病患者的关键健康结果进行详细而可靠的终生模拟。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号